AU2002306374A1 - Genes with ES cell-specific expression - Google Patents

Genes with ES cell-specific expression

Info

Publication number
AU2002306374A1
AU2002306374A1 AU2002306374A AU2002306374A AU2002306374A1 AU 2002306374 A1 AU2002306374 A1 AU 2002306374A1 AU 2002306374 A AU2002306374 A AU 2002306374A AU 2002306374 A AU2002306374 A AU 2002306374A AU 2002306374 A1 AU2002306374 A1 AU 2002306374A1
Authority
AU
Australia
Prior art keywords
genes
cell
specific expression
expression
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002306374A
Other versions
AU2002306374B2 (en
Inventor
Eiko Kaiho
Shinya Yamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority claimed from PCT/JP2002/005350 external-priority patent/WO2002097090A1/en
Publication of AU2002306374A1 publication Critical patent/AU2002306374A1/en
Assigned to YAMANAKA, SHINYA, DAINIPPON SUMITOMO PHARMA CO., LTD. reassignment YAMANAKA, SHINYA Request for Assignment Assignors: SUMITOMO PHARMACEUTICALS CO., LTD., YAMANAKA, SHINYA
Application granted granted Critical
Publication of AU2002306374B2 publication Critical patent/AU2002306374B2/en
Priority to AU2008201280A priority Critical patent/AU2008201280B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002306374A 2001-05-31 2002-05-31 Genes with ES cell-specific expression Ceased AU2002306374B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008201280A AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001165927 2001-05-31
JP2001-165927 2001-05-31
PCT/JP2002/005350 WO2002097090A1 (en) 2001-05-31 2002-05-31 Genes with es cell-specific expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008201280A Division AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Publications (2)

Publication Number Publication Date
AU2002306374A1 true AU2002306374A1 (en) 2003-05-08
AU2002306374B2 AU2002306374B2 (en) 2008-01-24

Family

ID=19008539

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002306374A Ceased AU2002306374B2 (en) 2001-05-31 2002-05-31 Genes with ES cell-specific expression
AU2008201280A Ceased AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008201280A Ceased AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Country Status (6)

Country Link
US (3) US7250255B2 (en)
EP (2) EP2354227B1 (en)
JP (2) JP4183614B2 (en)
AU (2) AU2002306374B2 (en)
ES (2) ES2633306T3 (en)
WO (1) WO2002097090A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072226A2 (en) * 2003-02-13 2004-08-26 Reprocell Inc. Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
US20090203141A1 (en) * 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
US7964401B2 (en) 2004-02-19 2011-06-21 Kyoto University Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3
WO2006035741A1 (en) * 2004-09-29 2006-04-06 Dainippon Sumitomo Pharma Co., Ltd. Gene expressed specifically in es cells and utilization of the same
US20100183617A1 (en) * 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
JP2008536803A (en) * 2005-02-23 2008-09-11 ユニバーシティ オブ バージニア パテント ファウンデーション A novel egg receptor for sperm protein
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
EP4223769A3 (en) * 2005-12-13 2023-11-01 Kyoto University Nuclear reprogramming factor
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US9382515B2 (en) 2007-04-07 2016-07-05 Whitehead Institute For Biomedical Research Reprogramming of somatic cells
US9213999B2 (en) * 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP2008307007A (en) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US20090239217A1 (en) * 2007-10-08 2009-09-24 University Of Florida Research Foundation, Inc. Stem-like cells in bone sarcomas
WO2009073523A2 (en) * 2007-11-29 2009-06-11 Children's Hospital Of Orange County De-differentiation of human cells
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
JP5558097B2 (en) 2007-12-10 2014-07-23 国立大学法人京都大学 Efficient nuclear initialization method
CA2621155A1 (en) * 2008-02-29 2009-08-29 James Ellis Stem cell expression cassettes
JP5346925B2 (en) * 2008-05-02 2013-11-20 国立大学法人京都大学 Nuclear initialization method
US9394538B2 (en) 2008-05-07 2016-07-19 Shi-Lung Lin Development of universal cancer drugs and vaccines
EP3231869A1 (en) 2008-06-13 2017-10-18 Whitehead Institute for Biomedical Research Programming and reprogramming of cells
BR112012011183A2 (en) 2009-11-12 2015-09-15 Vbi Technologies Llc isolated spore-like cell subpopulation and method for isolating a spore-like cell subpopulation
IL263224B2 (en) 2016-05-25 2024-03-01 Inst Nat Sante Rech Med Use of a histone deacetylase inhibitor and a population of inactivated pluripotent cells for treating cancer
WO2019101956A1 (en) 2017-11-24 2019-05-31 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for treating cancers
CN112703011A (en) 2018-08-06 2021-04-23 国家医疗保健研究所 Methods and compositions for treating cancer
WO2022207889A1 (en) 2021-04-01 2022-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679163A4 (en) 1993-01-12 1997-07-16 Univ Johns Hopkins Med Growth differentiation factor-3.
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
WO1999014372A1 (en) * 1997-09-15 1999-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins
AU5117799A (en) * 1998-07-24 2000-02-14 Eli Lilly And Company Human gdf-3 nucleic acids, polypeptides, vectors, host cells, methods and uses thereof
US6908748B2 (en) 1999-07-29 2005-06-21 Kenji Sobue Genes associated with the maintenance of differentiation of smooth muscle cells
WO2001009345A1 (en) 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
WO2001009316A1 (en) 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
AU7926400A (en) * 1999-10-15 2001-04-23 Ulla Aapola Novel gene encoding a dna methyltransferase, dnmt3l
JP2001165927A (en) 1999-12-08 2001-06-22 Ngk Insulators Ltd Method and apparatus for monitoring endocrine disturbing chemical substance
WO2001057266A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
FR2808803B1 (en) * 2000-05-11 2004-12-10 Agronomique Inst Nat Rech MODIFIED ES CELLS AND SPECIFIC GENE OF ES CELLS

Similar Documents

Publication Publication Date Title
AU2002306374A1 (en) Genes with ES cell-specific expression
EP1403366A4 (en) Genes with es cell-specific expression
AU2002313559A1 (en) Genes
AU2002259196A1 (en) Gene expression profiling
AU2003218483A1 (en) Novel expressed genes
AU2003277149A1 (en) Synthetic genes
AU2001278918A1 (en) Novel lipase genes
AUPQ262599A0 (en) Gene expression
AU2001242625A1 (en) Gene sequence
AU2003228139A1 (en) Bioreactor
AU2001240103A1 (en) Reproduction-specific genes
AU2001264247A1 (en) GASC1 gene
AU2001244358A1 (en) Schizophrenia related genes
AU2003234955A1 (en) Micromanipulator
GB0122232D0 (en) Gene expression
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2003222965A1 (en) Schizophrenia associated genes
AU2003294705A1 (en) NtSM GENE
AU2003243360A1 (en) Polyamine-mediated transfection
AUPR551201A0 (en) Neuronal cell-specific promoter
AU2001278042A1 (en) Daz genes
AUPR282501A0 (en) Expression facilitating nucleotides